Read more

June 11, 2020
1 min read
Save

Top in GI: Colorectal cancer in IBD, clinical hypnosis and Crohn’s disease

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

An analysis presented at Digestive Disease Week showed that patients with late-onset inflammatory bowel disease had a greater recurrence of colorectal cancer than patients with early-onset inflammatory bowel disease. It was the top story in gastroenterology last week.

Another top story was about the potential benefits of clinical hypnosis as a complementary therapy for children with Crohn’s disease. 

Read these and more popular news in gastroenterology below:

Greater recurrence of CRC in late-onset vs early onset IBD

Patients with late-onset inflammatory bowel disease had a greater recurrence of colorectal cancer than patients with early-onset, despite a shorter disease duration and strictly following recommended endoscopic surveillance guidelines, according to data from Digestive Disease Week. Read more.

Clinical hypnosis may improve pediatric Crohn’s disease pain

Clinical hypnosis that includes focused relaxation and therapeutic suggestion may be a promising complementary therapy for children with Crohn’s disease, according to research from Digestive Disease Week. Read more.

GI symptoms plus loss of taste, smell, fever highly specific to COVID-19

While gastrointestinal symptoms like anorexia and diarrhea are common in both patients with COVID-19 and those without, these symptoms plus a loss of smell, taste and fever were 99% specific for COVID-19, according to a study published in Gastroenterology. Read more.

High-dose vitamin D does not reduce endoscopic recurrence of Crohn’s

For patients who underwent ileocolonic resection with ileocolonic anastomosis, high-dose vitamin D did not reduce the incidence of postoperative endoscopic or clinical recurrence of Crohn’s disease, according to recently published results. Read more.

3 questions with the new ASGE president

Healio spoke with Klaus Mergener, MD, PhD, MBA, about what he hopes to accomplish in his year as president of the American Society for Gastrointestinal Endoscopy and how the society is helping its members navigate the uncertain time of the COVID-19 pandemic. Read more.